<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00473811</url>
  </required_header>
  <id_info>
    <org_study_id>5P30DK032520-24</org_study_id>
    <nct_id>NCT00473811</nct_id>
  </id_info>
  <brief_title>Diabetic Educational Eating Plan</brief_title>
  <acronym>DEEP</acronym>
  <official_title>Applicability of a Low Glycemic Index Diet in Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Massachusetts, Worcester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Massachusetts, Worcester</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      By improving glycemic control, many of the devastating complications of diabetes are to a&#xD;
      large extent preventable. The use of a low GI (glycemic index) diet to improve glycemic&#xD;
      control is relatively new and untested. However, a low GI diet may be a cost-effective&#xD;
      approach to preventing diabetes-related complications. The aim of this proposed 2-year study&#xD;
      is to gather pilot data on the feasibility of implementing a nutritionist-delivered low GI&#xD;
      intervention, to reduce dietary GI in patients with type 2 diabetes, and to compare it with a&#xD;
      nutritionist-delivered standard American Diabetes Association (ADA) diet intervention. Our&#xD;
      outcomes are recruitment and retention rates, as well as physiological measures (HbA1c, blood&#xD;
      lipids, blood pressure, and body mass index), dietary GI scores and acceptability of the&#xD;
      intervention.&#xD;
&#xD;
      Primary hypotheses:&#xD;
&#xD;
      1. Recruitment and retention rates for the low GI intervention will be satisfactory.&#xD;
&#xD;
      Secondary hypotheses:&#xD;
&#xD;
        1. Participants in the low GI intervention group will show more favorable changes in&#xD;
           physiological measures than participants in the ADA diet group.&#xD;
&#xD;
        2. Participants in the low GI group will be successful in lowering the GI of their diet.&#xD;
&#xD;
        3. Participants will find the intervention acceptable.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The glycemic index (GI) is a ranking of carbohydrate containing foods according to the rate&#xD;
      at which they raise blood glucose levels after eating. A recent meta-analysis of randomized&#xD;
      clinical trials (RCT) suggests that choosing low GI foods has a small but clinically useful&#xD;
      effect on medium-term glycemic control in patients with type 2 diabetes. However, in most of&#xD;
      the reviewed RCTs, patients were fed experimental diets and therefore there is still&#xD;
      controversy over the applicability of GI in the clinical setting for management of diabetes.&#xD;
      In addition, there is no evidence that long-term consumption of a low GI diet will contribute&#xD;
      to improved glycemic control in people with diabetes.&#xD;
&#xD;
      Our ultimate goal for a future larger RCT is to evaluate the long-term effects of using low&#xD;
      GI diet in type 2 diabetics. The primary outcome variable of the future large trial will be&#xD;
      glycosylated hemoglobin levels (HbA1c), a measure reflecting average glycemic level during&#xD;
      the preceding 2-3 months. The proposed feasibility study will recruit 40 patients with type 2&#xD;
      diabetes and will randomly assign them to one of two groups: a low GI nutrition education&#xD;
      group (low GI group) and a standard ADA dietary education group as the control group (ADA&#xD;
      group) (20 patients in each group).&#xD;
&#xD;
      For both groups, the intervention phase will last 6 months and consist of an initial group&#xD;
      session, an individual session, and then four group counseling sessions. The follow-up phase&#xD;
      will be six months and consist of two group booster sessions, one at 8-months and another at&#xD;
      10-months. The low GI nutritional education will be primarily targeted at a low GI diet. The&#xD;
      focus is not on decreasing total carbohydrate intake, but rather encouraging patients to&#xD;
      substitute low GI foods for high GI foods. The dietary intervention will be based on a&#xD;
      patient-centered counseling model which has been demonstrated to facilitate health behavior&#xD;
      change. Data collection points coincide with two phases of the intervention. Assessments,&#xD;
      including demographics, anthropometric measurements, diet and physical activity recalls, and&#xD;
      clinical data, will be conducted at baseline, and at 6 and 12 months after randomization,&#xD;
      with blood samples collected at each interval. We will track response to recruitment,&#xD;
      adherence, and retention. Quantitative and qualitative methods will be used to assess&#xD;
      acceptability of the intervention.&#xD;
&#xD;
      The aim of this proposed 2-year study is to gather pilot data on the feasibility of&#xD;
      implementing a nutritionist-delivered low GI intervention to reduce dietary GI in patients&#xD;
      with type 2 diabetes. Our outcomes are recruitment and retention rates, as well as&#xD;
      physiological measures (HbA1c, blood pressure, and body mass index), dietary GI scores and&#xD;
      acceptability of the intervention.&#xD;
&#xD;
      By improving glycemic control, many of the devastating complications of diabetes are to a&#xD;
      large extent preventable. The use of a low GI diet to improve glycemic control is relatively&#xD;
      new and untested. However, a low GI diet may be a cost-effective approach to preventing&#xD;
      diabetes-related complications. Testing the feasibility of such a program and its potential&#xD;
      impact would be an important step towards an RO1 application to the NIH.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2005</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Our outcomes are recruitment and retention rates, as well as physiological measures (HbA1c, blood pressure, and body mass index), dietary GI scores and acceptability of the intervention</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Low-GI Dietary Education</condition>
  <condition>ADA Dietary Education</condition>
  <arm_group>
    <arm_group_label>ADA diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be encouarged to consume foods consisted with ADA dietary recommendation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low-GI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a low GI dietary education</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low GI</intervention_name>
    <description>low-GI education</description>
    <arm_group_label>Low-GI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ADA diet</intervention_name>
    <description>ADA dietary education</description>
    <arm_group_label>ADA diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of type II diabetes in the medical chart&#xD;
&#xD;
          -  HbA1c level &gt;= 7 (an indication of poor control of diabetes)&#xD;
&#xD;
          -  Currently being treated with diet, oral hypoglycemic agents and/or insulin&#xD;
&#xD;
          -  At least 21 years old&#xD;
&#xD;
          -  Telephone in home or easy access to one&#xD;
&#xD;
          -  Able to understand study protocol&#xD;
&#xD;
          -  Understands and can provide informed consent&#xD;
&#xD;
          -  Physician's approval to participate in study&#xD;
&#xD;
          -  Has a blood glucose machine or a prescription for one from their physician&#xD;
&#xD;
          -  Able to speak and read English&#xD;
&#xD;
          -  Willing to be randomized to either of the two study groups&#xD;
&#xD;
          -  Able to participate in the study for a one year length of time.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or planning to become pregnant during the study&#xD;
&#xD;
          -  Unable or unwilling to provide informed consent&#xD;
&#xD;
          -  Plans to move out of the area within the 12-month study period&#xD;
&#xD;
          -  Required intermittent glucocorticoid therapy within the past 3 months&#xD;
&#xD;
          -  Documented acute coronary event (MI or unstable angina) within the past 6 months&#xD;
&#xD;
          -  Diagnosis of a medical condition that precludes adherence to study dietary&#xD;
             recommendations (e.g. Crohn's disease, ulcerative colitis, end-stage renal disease)&#xD;
&#xD;
          -  Diagnosis of a psychiatric illness (i.e. dementia, psychiatric hospitalization or&#xD;
             suicidality within the past 5 years). We will not exclude individuals with a diagnosis&#xD;
             of depression or patients taking anti-depressants.&#xD;
&#xD;
          -  Following a low-carbohydrate high fat dietary regimen such as the Atkins diet, or&#xD;
             currently following the South Beach Diet&#xD;
&#xD;
          -  Legally blind or has significant visual impairments&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yunsheng Ma, MD, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Preventive &amp; Behavioral Medicine, Department of Medicine, University of Massachusetts Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Massachusetts Medical School</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Ma Y, Olendzki BC, Hafner AR, Chiriboga DE, Culver AL, Andersen VA, Merriam PA, Pagoto SL. Low-carbohydrate and high-fat intake among adult patients with poorly controlled type 2 diabetes mellitus. Nutrition. 2006 Nov-Dec;22(11-12):1129-36. Epub 2006 Oct 4.</citation>
    <PMID>17027229</PMID>
  </results_reference>
  <results_reference>
    <citation>Ma Y, Olendzki BC, Merriam PA, Chiriboga DE, Culver AL, Li W, HÃ©bert JR, Ockene IS, Griffith JA, Pagoto SL. A randomized clinical trial comparing low-glycemic index versus ADA dietary education among individuals with type 2 diabetes. Nutrition. 2008 Jan;24(1):45-56.</citation>
    <PMID>18070658</PMID>
  </results_reference>
  <verification_date>August 2012</verification_date>
  <study_first_submitted>May 14, 2007</study_first_submitted>
  <study_first_submitted_qc>May 14, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2007</study_first_posted>
  <last_update_submitted>August 28, 2012</last_update_submitted>
  <last_update_submitted_qc>August 28, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 30, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Massachusetts, Worcester</investigator_affiliation>
    <investigator_full_name>Yunsheng Ma</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Glycemic index</keyword>
  <keyword>carbohydrates</keyword>
  <keyword>diabetes mellitus, type 2</keyword>
  <keyword>randomized clinical trial</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

